Description
Book SynopsisPharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world's poor see little effort to address diseases prevalent in less affluent societies, while the world's wealthy are overusing prescription drugs, risking their health and wasting resources.
The debate over health care reform and the ongoing global economic crisis form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform.
This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade.
Trade Review'There is a strong argument that people throughout the world have a right to receive the medicines they need in an appropriate, affordable, and timely way. Global Pharmaceutical Policy
describes the laws, policies, and customs relating to the development and provision of medicines, identifies their strengths and weakness, and then proposes global solutions for getting things better. Here is a masterpiece written in a clear and elegant style. Together, Dukes and Abbott have experience and insight that are unrivalled.' -- Joe Collier, Emeritus Professor of Medicines Policy, St George's, University of London, UK
Table of ContentsContents: Preface 1. The Challenges we Face 2. Promoting Innovation: Patents, Subsidies, Prizes and Prices 3. Policies on Innovation: Past, Present and Future 4. The Global Regulatory Environment: Quality, Safety and Efficacy 5. Medicines for the Developing World 6. The Use of Medicines: Education, Information and Persuasion 7. Regulation and the Role of the Courts 8. Specialized Policy Areas: Vaccines, Biologicals and Blood Products; Alternative and Traditional Medicines; Self-Medication; Counterfeit Medicines 9. The Rich, the Poor and the Neglected 10. Global and Regional Policies: The Way Ahead Index
